Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines.
Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines.
复制标题
DOI:
10.3390/molecules23071583
复制
发表时间:
2018-06-29
期刊:
影响因子:
--
通讯作者:
Guo Z
中科院分区:
文献类型:
--
作者:
Li Q;Guo Z
Many malignant cell surface carbohydrates resulting from abnormal glycosylation patterns of certain diseases can serve as antigens for the development of vaccines against these diseases. However, carbohydrate antigens are usually poorly immunogenic by themselves, thus they need to be covalently coupled with immunologically active carrier molecules to be functional. The most well established and commonly used carriers are proteins. In recent years, the use of toll-like receptor (TLR) ligands to formulate glycoconjugate vaccines has gained significant attention because TLR ligands can serve not only as carrier molecules but also as built-in adjuvants to form fully synthetic and self-adjuvanting conjugate vaccines, which have several advantages over carbohydrate-protein conjugates and formulated mixtures with external adjuvants. This article reviews recent progresses in the development of conjugate vaccines based on TLR ligands. Two major classes of TLR ligands, lipopeptides and lipid A derivatives will be covered with more focus on monophosohoryl lipid A (MPLA) and related analogs, which are TLR4 ligands demonstrated to be able to provoke T cell-dependent, adaptive immune responses. Corresponding conjugate vaccines have shown promising application potentials to multiple diseases including cancer.
登录
查看更多内容
影响因子:
7.3
作者:
Awate S;Babiuk LA;Mutwiri G
通讯作者:
Mutwiri G
影响因子:
1.8
作者:
DUMY, P;EGGLESTON, IM;MUTTER, M
通讯作者:
MUTTER, M
影响因子:
15.3
作者:
Avery, OT;Goebel, WF
通讯作者:
Goebel, WF
影响因子:
4.3
作者:
Cai, Hui;Huang, Zhi-Hua;Li, Yan-Mei
通讯作者:
Li, Yan-Mei
影响因子:
7.3
作者:
Amanda Shanks Huynh;Chung, Woo Jin;Vagner, Josef
通讯作者:
Vagner, Josef